Background Malignant struma ovarii (MSO) is a unique type of ovarian malignancy that data
on the survival outcome is limited and management strategy remains controversial due to its …

Background: Malignant struma ovarii (MSO) is an extremely rare ovarian malignant tumor
and there is limited data on the survival outcomes and prognostic predictors of MSO. The …

Aim To evaluate the clinico‐pathologic features, treatment options, prognostic factors, and
survival outcomes of malignant struma ovarii based on a systematic literature review in …

Background: Malignant struma ovarii (MSO) is a germ cell tumor of the ovary histologically
identical to differentiated thyroid cancers. There is a paucity of data on this neoplasm, with …

Background Struma ovarii (SO) is a rare tumor and may transform into ovarian strumal
carcinoid (OSC) and/or malignant struma ovarii (MSO), but the incidence, clinical …

OBJECTIVE: To review the clinicopathological experience of patients with benign and
malignant struma ovarii. METHOD: A retrospective institutional analysis of 2 patients with …

The natural history of 27 cases of biologically malignant struma ovarii from a series of 88
cases of histologically malignant or histologically proliferative struma ovarii is described. The …

Purpose Struma ovarii is rare, accounting for 0.3–1% of ovarian tumours. Malignant
transformation may occur, most often into papillary thyroid carcinoma. There is a paucity of …

Introduction Struma ovarii is a rare ovarian tumor, representing 0.5-1% of all ovarian tumors
and 2–5% of ovarian teratomas. It is defined as an ovarian teratoma composed mostly of …

Background: Struma ovarii is a rare monodermal ovarian teratoma composed predominantly
of mature thyroid tissue. Of these cases, 5–8% are clinically hyperthyroid and 5–10% of …